Otsuka (OTCMKTS:OTSKY) Sets New 1-Year High – Here’s What Happened

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $38.20 and last traded at $38.01, with a volume of 51121 shares changing hands. The stock had previously closed at $36.32.

Otsuka Stock Up 2.6%

The firm has a market cap of $41.29 billion, a P/E ratio of 15.44, a price-to-earnings-growth ratio of 7.65 and a beta of -0.04. The stock’s 50 day simple moving average is $34.27 and its 200 day simple moving average is $33.80. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17.

Otsuka (OTCMKTS:OTSKY) last issued its quarterly earnings data on Friday, July 31st. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a return on equity of 12.93% and a net margin of 15.50%.The firm had revenue of $4.41 billion during the quarter, compared to analyst estimates of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Research analysts anticipate that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.12 EPS for the current year.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.